MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Developmental Validity of the revised improved version of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS)

M. Tosin, G. Stebbins, C. Goetz, R. Hagerman, D. Hessl, M. Zolecki, P. Todd, M. Leehey, D. Hall (Chicago, USA)

Meeting: 2022 International Congress

Abstract Number: 886

Keywords: Fragile X tremor ataxia syndrome, Scales

Category: Rating Scales

Objective: To qualitatively validate the revised improved version of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS) for motor signs assessment.

Background: Clinimetric analyses of the first version of the FXTAS-RS showed weaknesses needing revision. Cognitive pretesting (CPT) is a qualitative approach used in scale development, preceding field testing, to assess the difficulty of examiners and examinees in completing the instrument.

Method: Rounds of CPT interviews were conducted with a convenience sample five movement disorders specialists and five patients with FXTAS following a semi-structured script and notes to determine whether the revised improved version of the FXTAS-RS is comprehensible, comprehensive, and relevant to capture the FXTAS motor signs. Insights gained from participants’ experiences using the FXTAS-RS were subjected to verbal protocol analysis (VPA) (1). VPA data were categorized according to comprehensibility, comprehensiveness, and relevance criteria, and were incorporated into the revised improved version of the scale between rounds.

Results: After the second round of the CPT, data saturation was reached, and no further adjustments were required. All insights incorporated into the revised improved version of the scale were categorized as comprehensibility criteria, since for all participants the revised version met the criteria of comprehensiveness and relevance.

Conclusion: Using an iterative approach, the FXTAS-RS demonstrated to be comprehensible, comprehensive, and relevant to assess motor signs in patients with FXTAS. The developmental validity of the revised improved version of the FXTAS-RS was established with the participation of professionals and patients and is now ready for field validation.

References: Stanton NA, Salmon PM, Rafferty LA, Walker GH, Baber C, Jenkins DP. Human Factors Methods. CRC Press; 2017.

To cite this abstract in AMA style:

M. Tosin, G. Stebbins, C. Goetz, R. Hagerman, D. Hessl, M. Zolecki, P. Todd, M. Leehey, D. Hall. Developmental Validity of the revised improved version of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS) [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/developmental-validity-of-the-revised-improved-version-of-the-fragile-x-associated-tremor-ataxia-syndrome-rating-scale-fxtas-rs/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/developmental-validity-of-the-revised-improved-version-of-the-fragile-x-associated-tremor-ataxia-syndrome-rating-scale-fxtas-rs/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley